| - GRCh37:
- Chr6:74303101-74320122
| SLC17A5 | | Salla disease | Likely pathogenic (Jan 6, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74189435-74363609
| EEF1A1, SLC17A5, MTO1 | | Salla disease | Uncertain significance (Jul 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74310064-74310174
| SLC17A5 | | Salla disease | Pathogenic (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74304800-74310184
| SLC17A5 | | Salla disease | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74320103-74320290
| SLC17A5 | | Salla disease | Pathogenic (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74363496-74363609
| SLC17A5 | | Salla disease | Pathogenic (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74310161
- GRCh38:
- Chr6:73600438
| SLC17A5 | | Salla disease | Likely benign (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351538
- GRCh38:
- Chr6:73641815
| SLC17A5 | G134V, G141V, G57V | Salla disease | Uncertain significance (Apr 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74345164
- GRCh38:
- Chr6:73635441
| SLC17A5 | K148E, K177E, K225E, K253E, K254E, K261E | Salla disease | Uncertain significance (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351526
- GRCh38:
- Chr6:73641803
| SLC17A5 | L138P, L145P, L61P | Salla disease | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354131
- GRCh38:
- Chr6:73644408
| SLC17A5 | T104M, T97M | Salla disease | Uncertain significance (Jul 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351445
- GRCh38:
- Chr6:73641722
| SLC17A5 | I165T, I172T, I88T | Salla disease | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74320229
- GRCh38:
- Chr6:73610506
| SLC17A5 | I308V, I279V, I332V, I384V, I385V, I392V, I356V | Salla disease | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74345129
- GRCh38:
- Chr6:73635406
| SLC17A5 | | Salla disease | Likely benign (Dec 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351483
- GRCh38:
- Chr6:73641760
| SLC17A5 | | Salla disease | Likely benign (Jul 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351518
- GRCh38:
- Chr6:73641795
| SLC17A5 | F141L, F148L, F64L | Salla disease | Uncertain significance (Jan 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74363503
- GRCh38:
- Chr6:73653780
| SLC17A5 | | Salla disease | Benign (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74320241
- GRCh38:
- Chr6:73610518
| SLC17A5 | A352P, A380P, A388P, A381P, A275P, A304P, A328P | Salla disease | Uncertain significance (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354224
- GRCh38:
- Chr6:73644501
| SLC17A5 | D66G, D73G | Salla disease | Uncertain significance (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74310101
- GRCh38:
- Chr6:73600378
| SLC17A5 | | Salla disease | Likely benign (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74331625
- GRCh38:
- Chr6:73621902
| SLC17A5 | I294L, I188L, I217L, I265L, I293L, I301L | Salla disease | Uncertain significance (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74320120
- GRCh38:
- Chr6:73610397
| SLC17A5 | | Salla disease | Uncertain significance (Jan 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74304824-74304826
- GRCh38:
- Chr6:73595101-73595103
| SLC17A5 | M458del, N435del, N487del, M521del, N382del, N411del, N488del, N495del, N459del | Salla disease | Uncertain significance (Jul 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351434
- GRCh38:
- Chr6:73641711
| SLC17A5 | A176P, A92P, A169P | Salla disease | Uncertain significance (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74325029
- GRCh38:
- Chr6:73615306
| SLC17A5 | | Salla disease | Likely benign (Sep 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74325023
- GRCh38:
- Chr6:73615300
| SLC17A5 | | Salla disease | Likely benign (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74348162
- GRCh38:
- Chr6:73638439
| SLC17A5 | S203G, S119G, S196G | Inborn genetic diseases, Salla disease | Uncertain significance (Feb 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:74363555
- GRCh38:
- Chr6:73653832
| SLC17A5 | R19C | Salla disease | Uncertain significance (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354188
- GRCh38:
- Chr6:73644465
| SLC17A5 | R78T, R85T | Salla disease | Uncertain significance (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74304869
- GRCh38:
- Chr6:73595146
| SLC17A5 | S506C, F420L, F472L, F444L, F473L, S443C, F367L, F396L, F480L | Salla disease | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354192
- GRCh38:
- Chr6:73644469
| SLC17A5 | N77D, N84D | Salla disease | Uncertain significance (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354345
- GRCh38:
- Chr6:73644622
| SLC17A5 | | Salla disease | Benign (Jun 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74310098
- GRCh38:
- Chr6:73600375
| SLC17A5 | | Salla disease | Likely benign (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74363501
- GRCh38:
- Chr6:73653778
| SLC17A5 | | Salla disease | Likely benign (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351660
- GRCh38:
- Chr6:73641937
| SLC17A5 | | Salla disease | Likely benign (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351566
- GRCh38:
- Chr6:73641843
| SLC17A5 | P132S, P48S, P125S | Salla disease | Uncertain significance (Sep 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74348158
- GRCh38:
- Chr6:73638435
| SLC17A5 | K204R, K197R, K120R | Salla disease | Uncertain significance (Aug 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74345144
- GRCh38:
- Chr6:73635421
| SLC17A5 | | Salla disease | Likely benign (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74348170
- GRCh38:
- Chr6:73638447
| SLC17A5 | L116P, L193P, L200P | Salla disease | Uncertain significance (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354294
- GRCh38:
- Chr6:73644571
| SLC17A5 | A43T | Salla disease | Uncertain significance (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354307
- GRCh38:
- Chr6:73644584
| SLC17A5 | | Salla disease | Likely benign (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74348217
- GRCh38:
- Chr6:73638494
| SLC17A5 | | Salla disease | Likely benign (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74304815
- GRCh38:
- Chr6:73595092
| SLC17A5 | M524T, M461T | Salla disease | Likely benign (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74348173
- GRCh38:
- Chr6:73638450
| SLC17A5 | P199fs, P192fs, P115fs | Salla disease | Pathogenic (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351460
- GRCh38:
- Chr6:73641737
| SLC17A5 | G83fs, G160fs, G167fs | Salla disease | Pathogenic (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74320180
- GRCh38:
- Chr6:73610457
| SLC17A5 | T401I, T348I, T400I, T295I, T372I, T324I, T408I | Salla disease | Uncertain significance (May 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74320105
- GRCh38:
- Chr6:73610382
| SLC17A5 | | Salla disease | Likely benign (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74345156
- GRCh38:
- Chr6:73635433
| SLC17A5 | | Salla disease | Likely benign (Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74346336
- GRCh38:
- Chr6:73636613
| SLC17A5 | | Salla disease | Likely benign (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74320233
- GRCh38:
- Chr6:73610510
| SLC17A5 | | Salla disease | Likely benign (Jan 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351532
- GRCh38:
- Chr6:73641809
| SLC17A5 | K59R, K136R, K143R | Salla disease | Likely pathogenic (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74320132
- GRCh38:
- Chr6:73610409
| SLC17A5 | I340T, I416T, I388T, I417T, I424T, I311T, I364T | Inborn genetic diseases, Salla disease | Uncertain significance (Apr 25, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:74363550
- GRCh38:
- Chr6:73653827
| SLC17A5 | R9H | Salla disease | Likely benign (Apr 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74363601
- GRCh38:
- Chr6:73653878
| SLC17A5 | | Salla disease | Likely benign (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74363509
- GRCh38:
- Chr6:73653786
| SLC17A5 | | Salla disease | Likely benign (Dec 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74304913
- GRCh38:
- Chr6:73595190
| SLC17A5 | V353M, V382M, V459M, V406M, V458M, V430M, V466M | Salla disease | Uncertain significance (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74345132
- GRCh38:
- Chr6:73635409
| SLC17A5 | | Salla disease | Likely benign (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74304914
- GRCh38:
- Chr6:73595191
| SLC17A5 | P428L, P491L | Salla disease | Likely benign (Dec 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351411
- GRCh38:
- Chr6:73641688
| SLC17A5 | | Salla disease | Uncertain significance (Dec 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74320200
- GRCh38:
- Chr6:73610477
| SLC17A5 | | Salla disease | Likely benign (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354241
- GRCh38:
- Chr6:73644518
| SLC17A5 | | Salla disease | Likely benign (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74304881
- GRCh38:
- Chr6:73595158
| SLC17A5 | L502S, L439S | Salla disease | Likely benign (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74325110
- GRCh38:
- Chr6:73615387
| SLC17A5 | Q270*, Q241*, Q294*, Q346*, Q347*, Q354*, Q318* | Salla disease | Pathogenic (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74331677
- GRCh38:
- Chr6:73621954
| SLC17A5 | | Salla disease | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351398
- GRCh38:
- Chr6:73641675
| SLC17A5 | | Salla disease | Likely benign (Dec 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351405
- GRCh38:
- Chr6:73641682
| SLC17A5 | | Salla disease | Likely benign (Jul 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74320221
- GRCh38:
- Chr6:73610498
| SLC17A5 | | Salla disease | Likely benign (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74345213
- GRCh38:
- Chr6:73635490
| SLC17A5 | | Salla disease | Likely benign (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354229
- GRCh38:
- Chr6:73644506
| SLC17A5 | | Salla disease | Likely benign (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351610
- GRCh38:
- Chr6:73641887
| SLC17A5 | W33*, W117*, W110* | Salla disease | Pathogenic (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74331597
- GRCh38:
- Chr6:73621874
| SLC17A5 | W197*, W226*, W303*, W310*, W274*, W302* | Salla disease | Pathogenic (Jun 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74325029
- GRCh38:
- Chr6:73615306
| SLC17A5 | | Salla disease | Likely benign (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74346346-74346361
- GRCh38:
- Chr6:73636623-73636638
| SLC17A5 | Y227fs, Y151fs, Y228fs, Y235fs | Salla disease | Pathogenic (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74304936
- GRCh38:
- Chr6:73595213
| SLC17A5 | N345S, N422S, N374S, T421A, N458S, N398S, N450S, N451S, T484A | Salla disease | Uncertain significance (May 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74363600
- GRCh38:
- Chr6:73653877
| SLC17A5 | P4A | Salla disease | Uncertain significance (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74345166
- GRCh38:
- Chr6:73635443
| SLC17A5 | Q147R, Q176R, Q224R, Q260R, Q252R, Q253R | Salla disease | Uncertain significance (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74331589
- GRCh38:
- Chr6:73621866
| SLC17A5 | Y306fs, Y277fs, Y305fs, Y313fs, Y229fs, Y200fs | Salla disease | Pathogenic (Jan 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354262
- GRCh38:
- Chr6:73644539
| SLC17A5 | | Salla disease | Likely benign (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74320185
- GRCh38:
- Chr6:73610462
| SLC17A5 | | Salla disease | Likely benign (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74320181
- GRCh38:
- Chr6:73610458
| SLC17A5 | T401A, T408A, T295A, T348A, T324A, T372A, T400A | Salla disease | Uncertain significance (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74345231
- GRCh38:
- Chr6:73635508
| SLC17A5 | | Salla disease | Likely benign (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354123
- GRCh38:
- Chr6:73644400
| SLC17A5 | | Salla disease | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74310075
- GRCh38:
- Chr6:73600352
| SLC17A5 | D373G, D421G, D344G, D450G, D397G, D449G, D457G | Salla disease | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74346364
- GRCh38:
- Chr6:73636641
| SLC17A5 | T150N, T226N, T227N, T234N | Salla disease | Uncertain significance (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74345239
- GRCh38:
- Chr6:73635516
| SLC17A5 | | Salla disease | Likely benign (Aug 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354155
- GRCh38:
- Chr6:73644432
| SLC17A5 | P89H, P96H | Salla disease | Uncertain significance (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74304919
- GRCh38:
- Chr6:73595196
| SLC17A5 | Q457*, Q351*, Q380*, Q404*, Q428*, Q456*, Q464* | Salla disease | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74363588
- GRCh38:
- Chr6:73653865
| SLC17A5 | L8V | Salla disease | Uncertain significance (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74363575
- GRCh38:
- Chr6:73653852
| SLC17A5 | D12G, M1V | Salla disease | Uncertain significance (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74310080
- GRCh38:
- Chr6:73600357
| SLC17A5 | | Salla disease | Likely benign (Jul 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74363609
- GRCh38:
- Chr6:73653886
| SLC17A5 | M1L | Salla disease | Pathogenic (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74363535
- GRCh38:
- Chr6:73653812
| SLC17A5 | A14E | Salla disease | Likely benign (Aug 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74354291
- GRCh38:
- Chr6:73644568
| SLC17A5 | I44V, I51V | Salla disease | Uncertain significance (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74310137
- GRCh38:
- Chr6:73600414
| SLC17A5 | | Salla disease | Likely benign (Aug 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74331648
- GRCh38:
- Chr6:73621925
| SLC17A5 | L180*, L209*, L257*, L285*, L286*, L293* | Sialic acid storage disease, severe infantile type, Salla disease | Likely pathogenic (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74325113-74325114
- GRCh38:
- Chr6:73615390-73615391
| SLC17A5 | G240fs, G269fs, G293fs, G317fs, G345fs, G346fs, G353fs | Sialic acid storage disease, severe infantile type, Salla disease | Likely pathogenic (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351502-74351503
- GRCh38:
- Chr6:73641779-73641780
| SLC17A5 | | Sialic acid storage disease, severe infantile type, Salla disease | Likely pathogenic (Apr 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74331589-74331590
- GRCh38:
- Chr6:73621866-73621867
| SLC17A5 | F199fs, F228fs, F276fs, F304fs, F305fs, F312fs | Sialic acid storage disease, severe infantile type, Salla disease | Likely pathogenic (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351617-74351618
- GRCh38:
- Chr6:73641894-73641895
| SLC17A5 | Q108fs, Q115fs, Q31fs | Sialic acid storage disease, severe infantile type, Salla disease | Likely pathogenic (Dec 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:74351549
- GRCh38:
- Chr6:73641826
| SLC17A5 | S131fs, S138fs, S54fs | Sialic acid storage disease, severe infantile type, Salla disease | Likely pathogenic (Mar 17, 2022) | criteria provided, single submitter |